KAZIA THERAPEUTICS
LIVE

Serial Number

79227049

Owner

Kazia Therapeutics Limited

Attorney

Sana Hakim

Filing Date

Sep 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

KAZIA THERAPEUTICS Trademark

Serial Number: 79227049 • Registration: 5640030

KAZIA THERAPEUTICS is a trademark filed by Kazia Therapeutics Limited on September 26, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Kazia Therapeutics Limited (3 trademarks)

Three International Towers,

Entity Type: 99

Trademark Details

Filing Date

September 26, 2017

Registration Date

January 1, 2019

Published for Opposition

October 16, 2018

Goods & Services

Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes

Chemicals used in science; chemical products for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals

Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 9, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 8, 2025 APRE
TEAS SECTION 71 RECEIVED
Jun 3, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 1, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 15, 2019 FICS
FINAL DISPOSITION PROCESSED
Apr 15, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 1, 2019 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 15, 2019 ADCH
REGISTERED-PRINCIPAL REGISTER
Jan 1, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 16, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Oct 12, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 26, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 26, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 26, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 10, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 10, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 10, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 10, 2018 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 10, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 4, 2018 PBCR
ASSIGNED TO LIE
Aug 23, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 13, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 13, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 13, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 13, 2018 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2018 REAP
REFUSAL PROCESSED BY IB
Mar 24, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 6, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 6, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 3, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2018 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2018 REPR